Abstract
Squamous cell carcinoma (SCC) immortality is associated with p53 and INK4A dysfunction, high levels of telomerase and loss of heterozygosity (LOH) of other chromosomes, including chromosome 4. To test for a functional cancer mortality gene on human chromosome 4 we introduced a complete or fragmented copy of the chromosome into SCC lines by microcell-mediated chromosome transfer (MMCT). Human chromosome 4 caused a delayed crisis, specifically in SCC lines with LOH on chromosome 4, but chromosomes 3, 6, 11 and 15 were without effect. The introduction of the telomerase reverse transcriptase into the target lines extended the average telomere terminal fragment length but did not affect the frequency of mortal hybrids following MMCT of chromosome 4. Furthermore, telomerase activity was still present in hybrids displaying the mortal phenotype. The MMCT of chromosomal fragments into BICR6 mapped the mortality gene to between the centromere and 4q23. Deletion analysis of the introduced chromosome in immortal segregants narrowed the candidate interval to 2.7 Mb spanning D4S423 and D4S1557. The results suggest the existence of a gene on human chromosome 4 whose dysfunction contributes to the continuous proliferation of SCC and that this gene operates independently from telomeres, p53 and INK4A.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Adra CN, Donato JL, Badovinac R, Syed F, Kheraj R, Cai H, Moran C, Kolker MT, Turner H, Weremowicz S, Shirakawa T, Morton CC, Schnipper LE, Drews R . 2000 Genomics 69: 162–173
Arribas R, Risques RA, Gonzalez-Garcia I, Masramon L, Aiza G, Ribas M, Capella G, Peinado MA . 1999 Lab. Invest. 79: 111–122
Backsch C, Wagenbach N, Nonn M, Leistritz S, Stanbridge E, Schneider A, Durst M . 2001 Genes Chromosomes Cancer 31: 196–198
Ben-Arie N, McCall AE, Berkman S, Eichele G, Bellen HJ, Zoghbi HY . 1996 Hum. Mol. Genet. 5: 1207–1216
Bertram MJ, Berube NG, Hang-Swanson X, Ran Q, Leung JK, Bryce S, Spurgers K, Bick RJ, Baldini A, Ning Y, Clark LJ, Parkinson EK, Barrett JC, Smith JR, Pereira-Smith OM . 1999 Mol. Cell. Biol. 19: 1479–1485
Bluteau O, Beaudoin JC, Pasturaud P, Belghiti J, Franco D, Bioulac-Sage P, Laurent-Puig P, Zucman-Rossi J . 2002 Oncogene 21: 1225–1232
Bryce SD, Forsyth NR, Fitzsimmons SA, Clark LJ, Bertram MJ, Cuthbert AP, Newbold RF, Pereira-Smith OM, Parkinson EK . 1999 Cancer Res. 59: 2038–2040
Buetow KH, Murray JC, Israel JL, London WT, Smith M, Kew M, Blanquet V, Brechot C, Redeker A, Govindarajah S . 1989 Proc. Natl. Acad. Sci. USA 86: 8852–8856
Casey G, Plummer S, Hoeltge G, Scanlon D, Fasching C, Stanbridge EJ . 1993 Hum. Mol. Genet. 2: 1921–1927
Clark LJ, Edington K, Swan IR, McLay KA, Newlands WJ, Wills LC, Young HA, Johnston PW, Mitchell R, Robertson G, Soutar D, Mitchell R, Parkinson EK, Birnie GD . 1993 Br. J. Cancer 68: 617–620
Cottage A, Dowen S, Roberts I, Pett M, Coleman N, Stanley M . 2001 Genes Chromosomes Cancer 30: 72–79
Cuthbert AP, Trott DA, Ekong RM, Jezzard S, England NL, Themis M, Todd CM, Newbold RF . 1995 Cytogenet. Cell Genet. 71: 68–76
Edington KG, Loughran OP, Berry IJ, Parkinson EK . 1995 Mol. Carcinog. 13: 254–265
England NL, Cuthbert AP, Trott DA, Jezzard S, Nobori T, Carson DA, Newbold RF . 1996 Carcinogenesis 17: 1567–1575
Hahn WC, Stewart SA, Brooks MW, York SG, Eaton E, Kurachi A, Beijersbergen RL, Knoll JH, Meyerson M, Weinberg RA . 1999 Nat. Med. 5: 1164–1170
Hensler PJ, Annab LA, Barrett JC, Pereira-Smith OM . 1994 Mol. Cell. Biol. 14: 2291–2297
Hu N, Roth MJ, Polymeropolous M, Tang ZZ, Emmert-Buck MR, Wang QH, Goldstein AM, Feng SS, Dawsey SM, Ding T, Zhuang ZP, Han XY, Ried T, Giffen C, Taylor PR . 2000 Genes Chromosomes Cancer 27: 217–228
Hu W, Zuo J, De Jager PL, Heintz N . 1998 Genomics 47: 143–145
Kanaoka Y, Ago H, Inagaki E, Nanayama T, Miyano M, Kikuno R, Fujii Y, Eguchi N, Toh H, Urade Y, Hayaishi O . 1997 Cell 90: 1085–1095
Karlsson C, Stenman G, Vojta PJ, Bongcam-Rudloff E, Barrett JC, Westermark B, Paulsson Y . 1996 Cancer Res. 56: 241–245
Koi M, Johnson LA, Kalikin LM, Little PF, Nakamura Y, Feinberg AP . 1993 Science 260: 361–364
Lee YA, Stevens HP, Delaporte E, Wahn U, Reis A . 2000 Am. J. Hum. Genet. 66: 326–330
Loughran O, Clark LJ, Bond J, Baker A, Berry IJ, Edington KG, Ly IS, Simmons R, Haw R, Black DM, Newbold RF, Parkinson EK . 1997 Oncogene 14: 1955–1964
Lupton SD, Brunton LL, Kalberg VA, Overell RW . 1991 Mol. Cell. Biol. 11: 3374–3378
McGregor F, Wagner E, Felix D, Soutar D, Parkinson K, Harrison PR . 1997 Cancer Res. 57: 3886–3889
Mitra AB, Murty VV, Li RG, Pratap M, Luthra UK, Chaganti RS . 1994 Cancer Res. 54: 4481–4487
Ning Y, Weber JL, Killary AM, Ledbetter DH, Smith JR, Pereira-Smith OM . 1991 Proc. Natl. Acad. Sci. USA 88: 5635–5639
Ogata T, Ayusawa D, Namba M, Takahashi E, Oshimura M, Oishi M . 1993 Mol. Cell. Biol. 13: 6036–6043
Parkinson EK, Newbold RF, Keith WN . 1997 Eur. J. Cancer 33: 727–734
Pershouse MA, El-Naggar AK, Hurr K, Lin H, Yung WK, Steck PA . 1997 Oncogene 14: 369–373
Petersen I, Langreck H, Wolf G, Schwendel A, Psille R, Vogt P, Reichel MB, Ried T, Dietel M . 1997 Br. J. Cancer 75: 79–86
Rimessi P, Gualandi F, Morelli C, Trabanelli C, Wu Q, Possati L, Montesi M, Barrett JC, Barbanti-Brodano G . 1994 Oncogene 9: 3467–3474
Robertson GP, Furnari FB, Miele ME, Glendening MJ, Welch DR, Fountain JW, Lugo TG, Huang HJ, Cavenee WK . 1998 Proc. Natl. Acad. Sci. USA 95: 9418–9423
Rumpel CA, Powell SM, Moskaluk CA . 1999 Am. J. Pathol. 154: 1329–1334
Sandhu AK, Hubbard K, Kaur GP, Jha KK, Ozer HL, Athwal RS . 1994 Proc. Natl. Acad. Sci. USA 91: 5498–5502
Sandhu AK, Kaur GP, Reddy DE, Rane NS, Athwal RS . 1996 Oncogene 12: 247–252
Sasaki M, Honda T, Yamada H, Wake N, Barrett JC, Oshimura M . 1994 Cancer Res. 54: 6090–6093
Shah SI, Yip L, Greenberg B, Califano JA, Chow J, Eisenberger CF, Lee DJ, Sewell DA, Reed AL, Lango M, Jen J, Koch WM, Sidransky D . 2000 Arch. Otolaryngol. Head Neck Surg. 126: 1073–1076
Shimada Y, Saito A, Suzuki M, Takahashi E, Horie M . 1998 Cytogenet. Cell Genet. 83: 232–235
Snedecor GW, Cochrane WG . 1973 Statistical Methods Iowa: Iowa State University Press
Soininen R, Schoor M, Henseling U, Tepe C, Kisters-Woike B, Rossant J, Gossler A . 1992 Mech. Dev. 39: 111–123
Stanton P, Richards S, Reeves J, Nikolic M, Edington K, Clark L, Robertson G, Souter D, Mitchell R, Hendler FJ, Cooke T, Parkinson EK, Ozanne B . 1994 Br. J. Cancer 70: 427–433
Stein GH . 1985 J. Cell Physiol. 125: 36–44
Tanner MM, Karhu RA, Nupponen NN, Borg A, Baldetorp B, Pejovic T, Ferno M, Killander D, Isola JJ . 1998 Am. J. Pathol. 153: 191–199
Terada Y, Imoto I, Nagai H, Suwa K, Momoi M, Tajiri T, Onda M, Inazawa J, Emi M . 2001 Am. J. Med. Genet. 103: 176–180
Uejima H, Mitsuya K, Kugoh H, Horikawa I, Oshimura M . 1995 Genes Chromosomes Cancer 14: 120–127
Vaziri H, Benchimol S . 1998 Curr. Biol. 8: 279–282
Virgin JB, Hurley PM, Nahhas FA, Bebchuk KG, Mohamed AN, Sakr WA, Bright RK, Cher ML . 1999 Prostate 41: 49–57
Wang XL, Uzawa K, Imai FL, Tanzawa H . 1999 Oncogene 18: 823–825
Wang XW, Lin X, Klein CB, Bhamra RK, Lee YW, Costa M . 1992 Carcinogenesis 13: 555–561
Zhu J, Wang H, Bishop JM, Blackburn EH . 1999 Proc. Natl. Acad. Sci. USA 96: 3723–3728
Zhu Z, Yao J, Johns T, Fu K, De Bie I, Macmillan C, Cuthbert AP, Newbold RF, Wang J, Chevrette M, Brown GK, Brown RM, Shoubridge EA . 1998 Nat. Genet. 20: 337–343
Acknowledgements
The authors wish to thank Cancer Research UK and the Association for International Cancer Research for financial support and Professors John Wyke and Paul Harrison for critical review of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Forsyth, N., Morrison, V., Craig, N. et al. Functional evidence for a squamous cell carcinoma mortality gene(s) on human chromosome 4. Oncogene 21, 5135–5147 (2002). https://doi.org/10.1038/sj.onc.1205688
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205688
Keywords
This article is cited by
-
Deletions in chromosome 4 differentially associated with the development of cervical cancer: evidence of slit2 as a candidate tumor suppressor gene
Human Genetics (2007)
-
Characterization of a conserved aphidicolin-sensitive common fragile site at human 4q22 and mouse 6C1: possible association with an inherited disease and cancer
Oncogene (2004)
-
Human squamous cell carcinomas lose a mortality gene from chromosome 6q14.3 to q15
Oncogene (2003)
-
A Mortality Gene(s) for the Human Adenocarcinoma Line HeLa Maps to a 130-kb Region of Human Chromosome 4q22-q23
Neoplasia (2002)